Índice triglicéridos-glucosa como marcador de resistencia a la insulina en adultos: Una revisión sistemática

Autores/as

DOI:

https://doi.org/10.61347/ei.v5iEsp.2.413

Palabras clave:

Índice TyG, resistencia a la insulina, riesgo cardiovascular, síndrome metabólico

Resumen

El índice triglicéridos-glucosa (TyG) se ha propuesto como un marcador indirecto de resistencia a la insulina (RI), aunque su desempeño frente a otros métodos de evaluación continua siendo objeto de investigación. El objetivo fue evaluar el desempeño del TyG como marcador indirecto de RI en adultos, mediante su comparación con el HOMA-IR y el clamp hiperinsulinémico-euglucémico, el análisis de sus asociaciones metabólicas y cardiovasculares y la descripción de los puntos de corte reportados en diferentes poblaciones. Se realizó una revisión sistemática conforme a PRISMA 2020, mediante búsquedas en PubMed/MEDLINE, Scopus y Web of Science de publicaciones comprendidas entre enero de 2020 y marzo de 2026. Se incluyeron estudios observacionales, revisiones sistemáticas y metaanálisis pertinentes. De 802 registros identificados inicialmente, se seleccionaron 20 publicaciones. Los resultados mostraron que el TyG presentó capacidad discriminativa para identificar RI, con un desempeño comparable o superior al HOMA-IR en determinadas poblaciones. Asimismo, sus valores elevados se asociaron con síndrome metabólico, hipertensión, rigidez arterial, aterosclerosis subclínica, eventos cardiovasculares y mortalidad. Los puntos de corte variaron según las características poblacionales, los criterios de referencia y las fórmulas de cálculo. Se concluyó que el TyG constituyó una herramienta accesible para complementar la evaluación de la RI y del riesgo cardiometabólico; sin embargo, la heterogeneidad de la evidencia impidió establecer un umbral universal o recomendar su utilización como sustituto de los métodos de referencia.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Accili, D., Deng, Z., & Liu, Q. (2025). Insulin resistance in type 2 diabetes mellitus. Nature Reviews Endocrinology, 21(7), 413–426. https://doi.org/10.1038/s41574-025-01114-y

Aman, M., Resnawita, D., Rasyid, H., Kasim, H., Bakri, S., Umar, H., Daud, N., & Seweng, A. (2021). The concordance of triglyceride glucose index (TyG index) and homeostatic model assessment for insulin resistance (HOMA-IR) in non-diabetic subjects of adult Indonesian males. Clinical Epidemiology and Global Health, 9, 227–230. https://doi.org/10.1016/j.cegh.2020.09.003

Castillo, Y., Mauro, V., Fairman, E., Charask, A., Olguín, L., Cáceres, L., & Barrero, C. (2023). Prognostic value of insulin resistance assessed by HOMA-IR in non-diabetic patients with decompensated heart failure. Current Problems in Cardiology, 48(6), 101112. https://doi.org/10.1016/j.cpcardiol.2022.101112

Chen, Q., Zhao, J., & Wang, W. (2025). Association between triglyceride glucose index and atrial fibrillation: A systematic review and meta-analysis. Asia Pacific Journal of Clinical Nutrition, 34(4), 502–515. https://doi.org/10.6133/apjcn.202508_34(4).0002

Dakota, I., Huang, W., Wijayanto, M., Nurhafizah, A., Khairunnisa, A., Rachmayanti, S., Yuliana, E., Sunjaya, A., & Siswanto, B. (2025). Prognostic value of triglyceride-glucose index on predicting major adverse cardiovascular events in hypertensive patients: A systematic review and meta-analysis. American Journal of Preventive Cardiology, 22, 100996. https://doi.org/10.1016/j.ajpc.2025.100996

D'Elia, L., Masulli, M., Rendina, D., Iacone, R., Russo, O., Zarrella, A. F., Abate, V., Strazzullo, P., & Galletti, F. (2024). Predictive role of triglyceride-glucose index and HOMA index on development of arterial stiffening in non-diabetic men. Nutrition, Metabolism and Cardiovascular Diseases, 34(11), 2464–2471. https://doi.org/10.1016/j.numecd.2024.07.005

D'Elia, L., Rendina, D., Iacone, R., Russo, O., Strazzullo, P., & Galletti, F. (2026). Triglyceride-glucose index, homeostatic model assessment index, and new-onset hypertension in middle-aged men. Journal of Hypertension, 44(1), 139–146. https://doi.org/10.1097/HJH.0000000000004162

Feng, J., Luo, R., Gao, J., Wang, Y., Cong, J., Ma, H., & Wu, X. (2025). Elevated triglyceride-glucose index is associated with insulin resistance, metabolic syndrome components, nonalcoholic fatty liver disease, and adverse pregnancy outcomes in Chinese women with polycystic ovary syndrome. Clinical Endocrinology, 103(3), 317–326. https://doi.org/10.1111/cen.15252

Guerrero-Romero, F., Villalobos-Molina, R., Jiménez-Flores, J., Simental-Mendia, L., Méndez-Cruz, R., Murguía-Romero, M., & Rodríguez-Morán, M. (2016). Fasting triglycerides and glucose index as a diagnostic test for insulin resistance in young adults. Archives of Medical Research, 47(5), 382–387. https://doi.org/10.1016/j.arcmed.2016.08.012

Lee, J. H., Jeon, S., Lee, H. S., & Lee, J. W. (2024). Trajectories of triglyceride-glucose index changes and their association with all-cause and cardiovascular mortality: A competing risk analysis. Cardiovascular Diabetology, 23(1), 364. https://doi.org/10.1186/s12933-024-02457-y

Lee, S. H., Park, S. Y., & Choi, C. S. (2022). Insulin resistance: From mechanisms to therapeutic strategies. Diabetes & Metabolism Journal, 46(1), 15–37. https://doi.org/10.4093/dmj.2021.0280

Luo, P., Cao, Y., Li, P., Li, W., Song, Z., Fu, Z., Zhou, H., Yi, X., Zhu, L., & Zhu, S. (2022). TyG Index Performs Better Than HOMA-IR in Chinese Type 2 Diabetes Mellitus with a BMI < 35 kg/m2: A Hyperglycemic Clamp Validated Study. Medicina, 58(7), 876. https://doi.org/10.3390/medicina58070876

Page, M., Moher, D., Bossuyt, P., Boutron, I., Hoffmann, T., Mulrow, C., Shamseer, L., Tetzlaff, J., Akl, E., Brennan, S., Chou, R., Glanville, J., Grimshaw, J., Hróbjartsson, A., Lalu, M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., . . . McKenzie, J. E. (2021). PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews. BMJ, 372, n160. https://doi.org/10.1136/bmj.n160

Primo, D., Izaola, O., & de Luis, D. A. (2023). Triglyceride-glucose index cutoff point is an accurate marker for predicting the prevalence of metabolic syndrome in obese Caucasian subjects. Annals of Nutrition and Metabolism, 79(2), 238–245. https://doi.org/10.1159/000526988

Rhaiem, T., Owczarek, A., Wójtowicz, M., Ciura, D., Madej, P., Chudek, J., & Olszanecka-Glinianowicz, M. (2025). The Cut-Off Value for the Triglyceride–Glucose Index (TyG) Discriminating Insulin Resistance Based on the SHBG Level and HOMA-IR Values in Women with Polycystic Ovary Syndrome. Life, 15(5), 691. https://doi.org/10.3390/life15050691

Sajdeya, O., Beran, A., Mhanna, M., Alharbi, A., Burmeister, C., Abuhelwa, Z., Malhas, S., Khader, Y., Sayeh, W., Assaly, R., & Moukarbel, G. (2022). Triglyceride glucose index for the prediction of subclinical atherosclerosis and arterial stiffness: A meta-analysis of 37,780 individuals. Current Problems in Cardiology, 47(12), 101390. https://doi.org/10.1016/j.cpcardiol.2022.101390

Son, D., Lee, H., Lee, Y., Lee, J., & Han, J. (2022). Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome. Nutrition, Metabolism and Cardiovascular Diseases, 32(3), 596–604. https://doi.org/10.1016/j.numecd.2021.11.017

Sun, Y., Ji, H., Sun, W., An, X., & Lian, F. (2025). Triglyceride glucose (TyG) index: A promising biomarker for diagnosis and treatment of different diseases. European Journal of Internal Medicine, 131, 3–14. https://doi.org/10.1016/j.ejim.2024.08.026

Szukiewicz, D. (2023). Molecular mechanisms for the vicious cycle between insulin resistance and the inflammatory response in obesity. International Journal of Molecular Sciences, 24(12), 9818. https://doi.org/10.3390/ijms24129818

Tahapary, D., Pratisthita, L., Fitri, N., Marcella, C., Wafa, S., Kurniawan, F., Rizka, A., Tarigan, T.., Harbuwono, D., Purnamasari, D., & Soewondo, P. (2022). Challenges in the diagnosis of insulin resistance: Focusing on the role of HOMA-IR and Tryglyceride/glucose index. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 16(8), 102581. https://doi.org/10.1016/j.dsx.2022.102581

Tai, S., Fu, L., Zhang, N., Zhou, Y., Xing, Z., & Wang, Y. (2022). Impact of baseline and trajectory of triglyceride-glucose index on cardiovascular outcomes in patients with type 2 diabetes mellitus. Frontiers in Endocrinology, 13, 858209. https://doi.org/10.3389/fendo.2022.858209

Vega-Cárdenas, M., Flores-Sánchez, J., Torres-Rodriguez, M., Sánchez-Armáss Capello, O., Vargas-Morales, J., Cossío-Torres, P., Terán-García, M., & Aradillas-García, C. (2022). Distribución del índice triglicéridos y glucosa (TyG) y el modelo homeostático para la evaluación de la resistencia a la insulina en la adolescencia tardía en mexicanos. Nutrición Hospitalaria, 39(6), 1349–1356. https://doi.org/10.20960/nh.04120

Wan, H., Cao, H., & Ning, P. (2024). Superiority of the triglyceride glucose index over the homeostasis model in predicting metabolic syndrome based on NHANES data analysis. Scientific Reports, 14(1), 15499. https://doi.org/10.1038/s41598-024-66692-9

Wang, X., Wu, L., Wang, S., Zhu, H., Cao, C., Chen, J., Hu, J., & Zhang, H. H. (2025). Triglyceride-glucose index in diabetic chronic complications in patients with type 2 diabetes mellitus. BMC Endocrine Disorders, 26(1), 2. https://doi.org/10.1186/s12902-025-02101-0

Wang, Y., Yang, W., & Jiang, X. (2021). Association between triglyceride-glucose index and hypertension: A meta-analysis. Frontiers in Cardiovascular Medicine, 8, 644035. https://doi.org/10.3389/fcvm.2021.644035

Yu, L., Li, Y., Ma, R., Guo, H., Zhang, X., Yan, Y., He, J., Wang, X., Niu, Q., & Guo, S. (2022). Construction of a personalized insulin resistance risk assessment tool in Xinjiang Kazakhs based on lipid- and obesity-related indices. Risk Management and Healthcare Policy, 15, 631–641. https://doi.org/10.2147/RMHP.S352401

Zheng, Y., Yin, G., Chen, F., Lin, L., & Chen, Y. (2022). Evaluation of triglyceride glucose index and homeostasis model of insulin resistance in patients with polycystic ovary syndrome. International Journal of Women's Health, 14, 1821–1829. https://doi.org/10.2147/IJWH.S387942

Zhong, H., Shao, Y., Guo, G., Zhan, Y., Liu, B., Shao, M., & Li, L. (2023). Association between the triglyceride-glucose index and arterial stiffness: A meta-analysis. Medicine, 102(10), e33194. https://doi.org/10.1097/MD.0000000000033194

Descargas

Publicado

2026-11-05

Cómo citar

Pástor Peñaherrera, N. F., & Chávez Villagomez, N. S. (2026). Índice triglicéridos-glucosa como marcador de resistencia a la insulina en adultos: Una revisión sistemática. Esprint Investigación, 5(Esp.2), 421–438. https://doi.org/10.61347/ei.v5iEsp.2.413